Role of electrochemotherapy in the treatment of metastatic melanoma and other metastatic and primary skin tumors

References

• Lens MB, Dawes M. Global perspectives of contemporary epidemiological trends of cutaneous malignant melanoma. Br. J. Dermatol.150(2), 179–185 (2004).
   PubMed Web of Science ®Google Scholar
• Thompson JF, Scolyer RA, Kefford RF. Cutaneous melanoma. Lancet365(9460), 687–701 (2005).
   PubMed Web of Science ®Google Scholar
• Eapen S, Dutcher JP. A review of evidence-based treatment of stage IIB to stage IV melanoma. Cancer Invest.23(4), 323–337 (2005).
   PubMedGoogle Scholar
• Bonenkamp JJ, Thompson JF, de Wilt JH, Doubrovsky A, de Faria Lima R, Kam PC. Isolated limb infusion with fotemustine after dacarbazine chemosensitisation for inoperable loco-regional melanoma recurrence. Eur. J. Surg. Oncol.30(10), 1107–1012 (2004).
   PubMed Web of Science ®Google Scholar
• Kroon BB, Fraker DL, Vrouenraets BC, Thompson JF. Isolated limb perfusion: results and complications. In: Textbook of Melanoma. Thompson JF, Morton DL, Kroon BBR (Eds). Martin Dunitz, London, UK, 410–428 (2004).
   Google Scholar
• Lindner P, Doubrovsky A, Kam P, Thompson J. Prognostic factors after isolated limb infusion with cytotoxic agents for melanoma. Ann. Surg. Oncol.9, 127–136 (2002).
   PubMed Web of Science ®Google Scholar
• McKay AJ, Byrne DS. Other treatments. In: Textbook of Melanoma. Thompson JF, Morton DL, Kroon BBR (Eds). Martin Dunitz, London, UK, 438–444 (2004).
   Google Scholar
• Schraffordt Koops H, Lejeune FJ, Kroon BBR, Klaase JM, Hoekstra HJ. Isolated limb perfusion: technical aspects. In: Textbook of Melanoma. Thompson JF, Morton DL, Kroon BBR (Eds). Martin Dunitz, London, UK, 404–409 (2004).
   Google Scholar
• Stevens G. Radiation therapy in locally advanced melanoma. In: Textbook of Melanoma. Thompson JF, Morton DL, Kroon BBR (Eds). Martin Dunitz, London, UK, 359–403 (2004).
   Google Scholar
• Stevens G, Thompson JF, Firth I, O'Brien CJ, McCarthy WH, Quinn MJ. Locally advanced melanoma: results of postoperative hypofractionated radiation therapy. Cancer88(1), 88–94 (2000).
   PubMedGoogle Scholar
• Thompson JF, Kam PC. Isolated limb infusion for melanoma: a simple but effective alternative to isolated limb perfusion. J. Surg. Oncol.88(1), 1–3 (2004).
   PubMed Web of Science ®Google Scholar
• Thompson JF, Kam PCA, de Wilt JHW, Lindner PI. Isolated limb infusion for melanoma. In: Textbook of Melanoma. Thompson JF, Morton DL, Kroon BBR (Eds). Martin Dunitz, London, UK, 429–437 (2004).
   Google Scholar
• Hersey P, Coates AS, McCarthy WH et al. Adjuvant immunotherapy of patients with high-risk melanoma using vaccinia viral lysates of melanoma: results of a randomized trial. J. Clin. Oncol.20(20), 4181–4190 (2002).
   PubMed Web of Science ®Google Scholar
• Byrne CM, Thompson JF, Johnston H et al. Treatment of metastatic melanoma using electroporation therapy with bleomycin (electrochemotherapy). Melanoma Res.15(1), 45–51 (2005).
   PubMed Web of Science ®Google Scholar
• Gothelf A, Mir LM, Gehl J. Electrochemotherapy: results of cancer treatment using enhanced delivery of bleomycin by electroporation. Cancer Treat. Rev.29(5), 371–387 (2003).
   PubMed Web of Science ®Google Scholar
• Gehl J. Electroporation: theory and methods, perspectives for drug delivery, gene therapy and research. Acta Physiol. Scand.177(4), 437–447 (2003)
   PubMedGoogle Scholar
• Jaroszeski M, Heller R, Gilbert R. In: Electrochemotherapy, Electrogenetherapy, and Transdermal Drug Delivery.Humana Press, Totowa, NJ, USA (2000).
   Google Scholar
• Neumann E, Schaefer-Ridder M, Wang Y, Hofschneider PH. Gene transfer into mouse lyoma cells by electroporation in high electric fields. EMBO J.1(7), 841–845 (1982).
   PubMed Web of Science ®Google Scholar
• Zimmermann U, Pilwat G, Vienken J. Erythrocytes and lymphocytes as drug carrier systems: techniques for entrapment of drugs in living cells. Recent Results Cancer Res.75, 252–259 (1980).
   PubMedGoogle Scholar
• Belehradek M, Domenge C, Luboinski B, Orlowski S, Belehradek J Jr, Mir LM. Electrochemotherapy, a new antitumor treatment. First clinical phase I–II trial. Cancer72(12), 3694–3700 (1993).
   PubMed Web of Science ®Google Scholar
• Gehl J, Skovsgaard T, Mir LM. Enhancement of cytotoxicity by electropermeabilization: an improved method for screening drugs. Anticancer Drugs9, 319–325 (1998).
   PubMed Web of Science ®Google Scholar
• Dinchuk JE, Kelley KA, Callahan GN. Flow cytometric analysis of transport activity in lymphocytes electroporated with a fluorescent organic anion dye. J. Immunol. Methods155(2), 257–265 (1992).
   PubMedGoogle Scholar
• Gabriel B, Teissie J. Direct observation in the millisecond time range of fluorescent molecule asymmetrical interaction with the electropermeabilized cell membrane. Biophys. J.73(5), 2630–2637 (1997).
   PubMed Web of Science ®Google Scholar
• Gehl J, Mir LM. Determination of optimal parameters for in vivo gene transfer by electroporation, using a rapid in vivo test for cell permeabilization. Biochem. Biophys. Res. Commun.261(2), 377–380 (1999).
   Google Scholar
• Neumann E, Kakorin S, Toensing K. Fundamentals of electroporative delivery of drugs and genes. Bioelectrochem. Bioenerg.48, 3–16 (1999).
   PubMed Web of Science ®Google Scholar
• Golzio M, Teissie J, Rols MP. Direct visualization at the single-cell level of electrically mediated gene delivery. Proc. Natl Acad. Sci. USA99(3), 1292–1297 (2002).
   PubMed Web of Science ®Google Scholar
• Mir LM, Bureau MF, Gehl J et al. High-efficiency gene transfer into skeletal muscle mediated by electric pulses. Proc. Natl Acad. Sci. USA96(8), 4262–4267 (1999).
   PubMed Web of Science ®Google Scholar
• Sukharev SI, Klenchin VA, Serov SM, Chernomordik LV, Chizmadzhev Yu A. Electroporation and electrophoretic DNA transfer into cells. The effect of DNA interaction with electropores. Biophys. J.63(5), 1320–1327 (1992).
   PubMed Web of Science ®Google Scholar
• Mir LM, Moller PH, Andre F, Gehl J. Electric pulse-mediated gene delivery to various animal tissues. Adv. Genet.54, 83–114 (2005).
   PubMed Web of Science ®Google Scholar
• Teissie J, Golzio M, Rols MP. Mechanisms of cell membrane electropermeabilization: a minireview of our present (lack of ?) knowledge. Biochim. Biophys. Acta1724(3), 270–280 (2005).
   PubMed Web of Science ®Google Scholar
• Dev NB, Preminger TJ, Hofmann GA, Dev SB. Sustained local delivery of heparin to the rabbit arterial wall with an electroporation catheter. Cathet. Cardiovasc. Diagn.45, 337–345 (1998).
   PubMedGoogle Scholar
• Allegretti JP, Panje WR. Electroporation therapy for head and neck cancer including carotid artery involvement. Laryngoscope111(1), 52–56 (2001).
   PubMed Web of Science ®Google Scholar
• Gehl J, Geertsen PF. Efficient palliation of haemorrhaging malignant melanoma skin metastases by electrochemotherapy. Melanoma Res.10(6), 585–589 (2000).
   PubMed Web of Science ®Google Scholar
• Glass LF, Fenske NA, Jaroszeski M et al. Bleomycin-mediated electrochemotherapy of basal cell carcinoma. J. Am. Acad. Dermatol.34(1), 82–86 (1996).
   PubMed Web of Science ®Google Scholar
• Glass LF, Pepine ML, Fenske NA, Jaroszeski M, Reintgen DS, Heller R. Bleomycin-mediated electrochemotherapy of metastatic melanoma. Arch. Dermatol.132(11), 1353–1357 (1996).
   PubMed Web of Science ®Google Scholar
• Heller R, Jaroszeski MJ, Reintgen DS et al. Treatment of cutaneous and subcutaneous tumors with electrochemotherapy using intralesional bleomycin. Cancer83(1), 148–157 (1998).
   PubMed Web of Science ®Google Scholar
• Sersa G, Cufer T, Cemazar M, Rebersek M, Zvonimir R. Electrochemotherapy with bleomycin in the treatment of hypernephroma metastasis: case report and literature review. Tumori86(2), 163–165 (2000).
   PubMed Web of Science ®Google Scholar
• Sersa G, Stabuc B, Cemazar M, Miklavcic D, Rudolf Z. Electrochemotherapy with cisplatin: clinical experience in malignant melanoma patients. Clin. Cancer Res.6(3), 863–867 (2000).
   PubMed Web of Science ®Google Scholar
• Rols MP, Bachaud JM, Giraud P, Chevreau C, Roche H, Teissie J. Electrochemotherapy of cutaneous metastases in malignant melanoma. Melanoma Res.10(5), 468–474 (2000).
   PubMed Web of Science ®Google Scholar
• Snoj M, Rudolf Z, Cemazar M, Jancar B, Sersa G. Successful sphincter-saving treatment of anorectal malignant melanoma with electrochemotherapy, local excision and adjuvant brachytherapy. Anticancer Drugs16(3), 345–348 (2005).
   PubMed Web of Science ®Google Scholar
• Mir LM, Glass LF, Sersa G et al. Effective treatment of cutaneous and subcutaneous malignant tumours by electrochemotherapy. Br. J. Cancer77(12), 2336–2342 (1998).
   PubMed Web of Science ®Google Scholar
• Sersa G, Cemazar M, Miklavcic D, Chaplin DJ. Tumor blood flow modifying effect of electrochemotherapy with bleomycin. Anticancer Res.19, 4017–4022 (1999).
   PubMed Web of Science ®Google Scholar
• Sersa G, Cemazar M, Parkins CS, Chaplin DJ. Tumour blood flow changes induced by application of electric pulses. Eur. J. Cancer35, 672–677 (1999).
   PubMed Web of Science ®Google Scholar
• Gehl J, Skovsgaard T, Mir LM. Vascular reactions to in vivo electroporation: characterization and consequences for drug and gene delivery. Biochim. Biophys. Acta1569(1–3), 51–58 (2002).
   PubMed Web of Science ®Google Scholar
• Cemazar M, Parkins CS, Holder AL, Chaplin DJ, Tozer GM, Sersa G. Electroporation of human microvascular endothelial cells: evidence for an anti-vascular mechanism of electrochemotherapy. Br. J. Cancer84(4), 565–570 (2001).
   PubMed Web of Science ®Google Scholar
• Mir LM, Tounekti O, Orlowski S. Bleomycin: revival of an old drug. Gen. Pharmacol.27, 745–748 (1996).
   PubMedGoogle Scholar
• Orlowski S, Belehradek J Jr, Paoletti C, Mir LM. Transient electropermeabilization of cells in culture. Increase of the cytotoxicity of anticancer drugs. Biochem. Pharmacol.37(24), 4727–4733 (1988).
   PubMed Web of Science ®Google Scholar
• Kuriyama S, Matsumoto M, Mitoro A et al. Electrochemotherapy for colorectal cancer with commonly used chemotherapeutic agents in a mouse model. Dig. Dis. Sci.45(8), 1568–1577 (2000).
   PubMedGoogle Scholar
• Mitoro A, Kuriyama S, Tsujinoue H, Matsumoto M, Nakatani T, Fukui H. Electrochemotherapy with bleomycin against colorectal carcinoma in a mouse model: evaluations of the dose and administration route of the drug and the electric field intensity. Int. J. Oncol.16(1), 97–104 (2000).
   PubMedGoogle Scholar
• Nanda GS, Sun FX, Hofmann GA, Hoffman RM, Dev SB. Electroporation enhances therapeutic efficacy of anticancer drugs: treatment of human pancreatic tumor in animal model. Anticancer Res.18(3A), 1361–1366 (1998).
   PubMed Web of Science ®Google Scholar
• Salford LG, Persson BR, Brun A, Ceberg CP, Kongstad PC, Mir LM. A new brain tumour therapy combining bleomycin with in vivo electropermeabilization. Biochem.Biophys. Res. Commun.194(2), 938–943 (1993).
   Google Scholar
• Yamaguchi O, Irisawa C, Baba K, Ogihara M, Yokota T, Shiraiwa Y. Potentiation of antitumor effect of bleomycin by local electric pulses in mouse bladder tumor. Tohoku J. Exp. Med.172(3), 291–293 (1994).
   PubMedGoogle Scholar
• Jaroszeski MJ, Dang V, Pottinger C, Hickey J, Gilbert R, Heller R. Toxicity of anticancer agents mediated by electroporation in vitro. Anticancer Drugs11(3), 201–208 (2000).
   PubMed Web of Science ®Google Scholar
• Heller R, Jaroszeski MJ, Glass LF et al. Phase I/II trial for the treatment of cutaneous and subcutaneous tumors using electrochemotherapy. Cancer77(5), 964–971 (1996).
   PubMed Web of Science ®Google Scholar
• Glass LF, Jaroszeski M, Gilbert R, Reintgen DS, Heller R. Intralesional bleomycin-mediated electrochemotherapy in 20 patients with basal cell carcinoma. J. Am. Acad. Dermatol.37(4), 596–599 (1997).
   PubMed Web of Science ®Google Scholar
• Rodriguez-Cuevas S, Barroso-Bravo S, Almanza-Estrada J, Cristobal-Martinez L, Gonzalez-Rodriguez E. Electrochemotherapy in primary and metastatic skin tumors: Phase II trial using intralesional bleomycin. Arch. Med. Res.32(4), 273–276 (2001).
   PubMed Web of Science ®Google Scholar
• Sersa G, Stabuc B, Cemazar M, Miklavcic D, Rudolf Z. Electrochemotherapy with cisplatin: the systemic antitumour effectiveness of cisplatin can be potentiated locally by the application of electric pulses in the treatment of malignant melanoma skin metastases. Melanoma Res.10(4), 381–385 (2000).
   PubMed Web of Science ®Google Scholar
• Panje WR, Hier MP, Garman GR, Harrell E, Goldman A, Bloch I. Electroporation therapy of head and neck cancer. Ann. Otol. Rhinol. Laryngol.107(9 Pt 1), 779–785 (1998).
   PubMed Web of Science ®Google Scholar
• Hofmann GA, Dev SB, Dimmer S, Nanda GS. Electroporation therapy: a new approach for the treatment of head and neck cancer. IEEE Trans. Biomed. Eng.46(6), 752–759 (1999).
   PubMed Web of Science ®Google Scholar
• Bloom DC, Goldfarb PM. The role of intratumour therapy with electroporation and bleomycin in the management of advanced squamous cell carcinoma of the head and neck. Eur. J. Surg. Oncol.31, 1029–1035 (2005).
   Google Scholar
• Burian M, Formanek M, Regele H. Electroporation therapy in head and neck cancer. Acta Otoaryngol.123(2), 264–268 (2003).
   PubMed Web of Science ®Google Scholar
• Hena MA, Emrich LJ, Nambisan RN, Karakousis CP. Effect of surgical treatment on stage IV melanoma. Am. J. Surg.153, 270–275 (1987).
   PubMedGoogle Scholar
• Ho R. Medical management of stage IV malignant melanoma. Medical issues. Cancer75, 735–741 (1995).
   PubMed Web of Science ®Google Scholar
• Aapro M. Advances in systemic treatment of malignant melanoma. Eur. J. Cancer29A, 613–617 (1993).
   PubMedGoogle Scholar
• Fletcher W, Daniels D, Sondak V, Dana B, Townsend R, Hynes H. Evaluation of cisplatin and DTIC in inoperable stage III and IV melanoma. A Southwest Oncology Group study. Am. J. Clin. Oncol.16, 359–362 (1993).
   PubMedGoogle Scholar
• Rose DM, Essner R, Hughes TM et al. Surgical resection for metastatic melanoma to the liver: the John Wayne Cancer Institute and Sydney Melanoma Unit experience. Arch. Surg.136(8), 950–955 (2001).
   PubMedGoogle Scholar
• Bleicher R, Allegra D, Nora D, Wood T, Foshag L, Bilchik A. Radiofrequency ablation in 447 complex unresectable liver tumors: lessons learned. Ann. Surg. Oncol.10, 52–58 (2003).
   PubMed Web of Science ®Google Scholar
• Tait I, Yong S, Cuschieri S. Laparoscopic in situ ablation of liver cancer with cryotherapy and radiofrequency ablation. Br. J. Surg.89, 1613–1619 (2002).
   PubMedGoogle Scholar